3/6/2014 7:27:28 AM
Ampio Pharmaceuticals announced today it has raised net proceeds of $63.3 million following the completion of an underwritten public offering. Ampio (NYSE: AMPE), which is based in Greenwood Village, CO, focuses on developing therapies for inflammatory conditions. Its two most advanced drug candidates are aspartyl-alanyl diketopiperazine (Ampion), which could be used to treat osteoarthritis of the knee, and a reformulation of the generic oral steroid danazol (Optina), a potential treatment for diabetic macular edema, which affects the eye.
Help employers find you! Check out all the jobs and post your resume.
comments powered by